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Abstract Enzymes from hyperthermophiles can be efficiently
purified after expression in mesophilic hosts and are well-suited
for crystallisation attempts. Two enzymes of histidine biosyn-
thesis from Thermotoga maritima, NP-((5P-phosphoribosyl)-
formimino)-5-aminoimidazol-4-carboxamid ribonucleotide isom-
erase and the cyclase moiety of imidazoleglycerol phosphate
synthase, were overexpressed in Escherichia coli, both in their
native and seleno-methionine-labelled forms, purified by heat
precipitation of host proteins and crystallised. NP-((5P-phosphori-
bosyl)-formimino)-5-aminoimidazol-4-carboxamid ribonucleo-
tide isomerase crystallised in four different forms, all suitable
for X-ray structure solution, and the cyclase moiety of
imidazoleglycerol phosphate synthase yielded one crystal form
that diffracted to atomic resolution. The obtained crystals will
enable the determination of the first three-dimensional structures
of enzymes from the histidine biosynthetic pathway.
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1. Introduction
The histidine biosynthesis is an ancient and key metabolic
pathway that comprises 11 enzymatic reactions that are en-
coded by eight genes in the enterobacteria [1]. The operon
organisation of the his genes and the regulation of their ex-
pression as well as the catalytic and regulatory properties of
the corresponding enzymes have been studied intensively [1,2].
However, in contrast to related amino acid biosynthetic path-
ways such as tryptophan biosynthesis [3], three-dimensional
structures are not yet available for any of the enzymes of
the histidine biosynthesis.
Structure determination using X-ray di¡raction has rapidly
progressed in recent years, mostly by the advances in a variety
of phasing methods and the increased availability of synchro-
tron facilities. Thus, in many projects, the sample preparation
by overexpression, puri¢cation and crystallisation of the pro-
teins has become the rate-limiting step in the structural anal-
ysis. When working with bacterial proteins, the corresponding
variants from hyperthermophiles o¡er considerable advan-
tages in sample preparation compared to their mesophilic or-
thologues, due to their high intrinsic stability and high solu-
bility [4]. Furthermore, due to the usually weak catalytic
activity of hyperthermostable enzymes at low temperatures,
enzyme-substrate complexes might have a su⁄ciently high
lifetime for X-ray analysis.
Hence, we have initiated the structural analysis of several
histidine biosynthetic enzymes from the hyperthermophilic
bacterium Thermotoga maritima, where the his gene cluster
thisDCBdHAFI-E was recently sequenced and characterised
[5]. Here, we describe the heterologous expression in Esche-
richia coli, puri¢cation and crystallisation of NP-((5P-phos-
phoribosyl)-formimino)-5-aminoimidazol-4-carboxamid ribo-
nucleotide isomerase (the product of the thisA gene, tHisA)
and of the cyclase subunit of imidazoleglycerol phosphate
synthase (the product of the thisF gene, tHisF). tHisA (241
residues) and tHisF (253 residues) have 25% sequence identity.
Both HisA and HisF have been predicted to have evolved
from a common ancestor by a series of gene duplication
and diversi¢cation events [6] and to comprise the (LK)8-barrel
fold [5,7^9]. The structure determination of tHisA and tHisF
by multiple wavelength anomalous di¡raction (MAD) analy-
sis of native and seleno-methionine (SeMet)-labelled will allow
for testing these predictions.
2. Materials and methods
2.1. Expression and puri¢cation of tHisA
The hisA gene of T. maritima (thisA) was ampli¢ed by PCR, using
the plasmid pUN121/I [5] as a template. The oligonucleotide pDS-
thisA(upper) 5P-AAGGTGATCGCATGCTCGTTG-3P with a SphI
site (in bold) was used as the 5P-primer and the oligonucleotide
pDS-thisA(lower) 5P-GAGACACGCGATTAAGCTTTTAGC-3P with
a HindIII site (in bold) as the 3P-primer. Using the two new restriction
sites, the ampli¢ed DNA fragment was cloned into the expression
plasmid pDS/RBSII [10] to yield the plasmid pDS/RBSII/thisA. Ex-
pression was conducted in W3110 trpEA2 cells [11] containing the
repressor plasmid pDMI,1 [12]. An overnight culture of freshly trans-
formed cells in 500 ml LB medium supplemented with 0.15 mg/ml
ampicillin and 0.025 mg/ml kanamycin was used to inoculate a fer-
menter (Bioengineering, Wald, Switzerland) containing 38 l of the
same medium. The culture was incubated at 37‡C with a constant
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air supply (5 l/min) and continuous stirring (200 rpm). Overexpression
of thisA was induced at an optical density at 600 nm (OD600) of 0.56
by adding IPTG to a ¢nal concentration of 1 mM. After another 5 h
of incubation, the cells reached an OD600 of 4.4 and were harvested in
a £ow-through centrifuge (CEPA Z41G, Lahr, Germany) at 20 000
rpm, washed with 100 mM potassium phosphate bu¡er at pH 7.5 and
centrifuged again (Sorvall GS3, 12 000 rpm, 20 min, 4‡C). About 182 g
cells (wet weight) was obtained, corresponding to 4.8 g/l culture.
The cells were resuspended at 4‡C in 100 mM potassium phosphate
bu¡er at pH 7.5, containing 5 mM EDTA, 1 mM DTT, 0.3 mM
phenylmethylsulfonyl£uoride, 5 Wg/ml of both DNAse and RNAse
(1.5 ml bu¡er/g wet mass), and disrupted by soni¢cation (Branson
Soni¢er 250, 2U3 min, 50% pulse, output control 6, 0‡C). The result-
ing homogenate was centrifuged (Sorvall GSA, 12 000 rpm, 60 min,
4‡C). According to SDS-PAGE, about 90% of tHisA was found in the
soluble and 10% in the insoluble fraction. The supernatant was heated
to 75‡C for 15 min, the suspension was centrifuged (Sorvall GSA,
12 000 rpm, 60 min, 4‡C) and the pellet discarded. The supernatant
was dialysed at 4‡C against 50 mM Tris-HCl bu¡er at pH 7.5, con-
taining 2 mM EDTA and 0.5 mM DTT, and loaded on a DEAE-
Sephacel fast-£ow column (5U29.6 cm, Pharmacia) that was equili-
brated with the same bu¡er. The column was washed with two vol-
umes of equilibration bu¡er and then eluted with 3 l of a linear
gradient from 0 to 500 mM NaCl. Fractions judged by SDS-PAGE
to contain tHisA were pooled, dialysed against 50 mM Tris-HCl
bu¡er at pH 7.5, 1 mM EDTA, 0.5 mM DTT, and loaded on a
Red Sepharose CL-6B column (2.5U16.5 cm, Pharmacia) that was
equilibrated with the same bu¡er. The column was washed with ¢ve
volumes of equilibration bu¡er and eluted with 800 ml of a linear
gradient of 0 to 500 mM NaCl. The main UV-absorbing peak con-
tained tHisA with a purity above 98%, as judged by SDS-PAGE and
reversed phase HPLC. The puri¢cation yielded approximately 1.15 mg
tHisA/g wet cells, corresponding to 0.2 l cell culture. Fractions con-
taining pure tHisA were pooled, dialysed against 10 mM potassium
phosphate at pH 7.5, containing 1 mM EDTA and 0.5 mM DTT,
concentrated to 20^29 mg/ml by ultra¢ltration (PM 10 membranes,
Amicon) and shock-frozen in liquid nitrogen.
For crystallisation attempts, puri¢ed tHisA at a concentration of
10 mg/ml was dialysed against 10 mM HEPES/NaOH bu¡er at pH
7.4, containing 1 mM DTT and 1 mM EDTA.
2.2. Expression and puri¢cation of tHisF
The hisF gene of T. maritima (thisF) was ampli¢ed by PCR, using
the plasmid pUN121/I [5] as a template. The oligonucleotide pET-
HisF-U 5P-TGATGAAGACATATGCTCGCTAAAAG-3P with a
NdeI site (in bold) was used as the 5P-primer and the oligonucleotide
pET-HisF-L 5P-CCGGATCCAGCGTCATCACAA-3P with a BamHI
site (in bold) as the 3P-primer. Using the two new restriction sites, the
ampli¢ed DNA fragment was cloned into the expression plasmid
pET11c to yield the plasmid pET11c-thisF. Expression was conducted
in E. coli BL21(DE 3) cells, which contain the gene for the phage T7
polymerase on their chromosome [13]. An overnight culture of freshly
transformed cells containing 1 l LB medium supplemented with
0.1 mg/ml ampicillin was used to inoculate the 38 l fermenter as
described for tHisA. For reasons unexplained so far, the presence of
IPTG inhibits expression of thisF. Therefore, cells were grown over-
night at 37‡C without addition of IPTG, resulting in an OD600 value
of 5. Cells were harvested in a £ow-through centrifuge (CEPA GLE,
Lahr, Germany) at 40000 rpm, washed with 100 mM potassium phos-
phate bu¡er at pH 7.8, containing 2 mM EDTA and 1 mM DTT, and
centrifuged again (Sorvall GS3, 5000 rpm, 7 min, 4‡C). About 195 g
cells (wet weight) was obtained, corresponding to 5.3 g/l culture.
The cells were resuspended (0.5 ml bu¡er for 1 g wet mass) in
100 mM potassium phosphate bu¡er at pH 7.8, containing 5 mM
EDTA, 1 mM DTT, 1.2 Wg/ml DNAse, 0.4 Wg/ml RNAse. About
100 g wet cells was disrupted by soni¢cation (Branson Soni¢er 250,
2U2 min, 50% pulse, output control 5^6, 0‡C). The resulting ho-
mogenate was centrifuged (Sorvall GSA, 12 000 rpm, 45 min, 4‡C).
According to SDS-PAGE, about equal amounts of tHisF were found
in the insoluble and soluble fractions. The supernatant was heated to
75‡C for 15 min and centrifuged (Sorvall GSA, 12 000 rpm, 60 min,
4‡C) and the pellet discarded. The supernatant was dialysed against
10 mM potassium phosphate, pH 7.8, containing 2 mM EDTA and
1 mM DTT, and loaded on a DEAE-Sepharose fast-£ow column
(5U29.6 cm, Pharmacia) that was equilibrated with the same bu¡er,
at 4‡C. The column was washed with two volumes of equilibration
bu¡er and bound proteins were eluted with 3 l of a linear gradient of
10^500 mM potassium phosphate at pH 7.8, containing 1 mM DTT.
tHisF eluted between 220 mM and 255 mM potassium phosphate, as
judged from SDS-PAGE and conductivity measurements. Fractions
containing tHisF were pooled, dialysed against 10 mM potassium
phosphate at pH 7.5 containing 1 mM DTT, loaded on a hydroxyla-
patite column (3.6U20 cm) and eluted as described above for the
DEAE-Sepharose fast-£ow column. tHisF eluted between 15 and
85 mM potassium phosphate. The main UV-absorbing peak con-
tained tHisF with a purity above 95%, as judged by SDS-PAGE
and reversed phase HPLC. The puri¢cation yielded approximately
2.3 mg tHisF/g wet cells, corresponding to 0.2 l cell culture. Fractions
containing pure tHisF were pooled, dialysed against 50 mM potassi-
um phosphate at pH 7.0, containing 2 mM EDTA and 1 mM DTT,
concentrated to 31 mg/ml by ultra¢ltration (PM 10 membranes, Ami-
con) and shock-frozen in liquid nitrogen.
For crystallisation attempts, tHisF at a concentration of 16 mg/ml
was dialysed against 10 mM Bis-Tris bu¡er at pH 7.2, containing
1 mM DTT and 1 mM EDTA.
2.3. Expression and puri¢cation of SeMet derivatives of tHisA and
tHisF
Since the methionine-de¢cient strain B834(DE3)/pLys requires the
use of pET vectors for the heterologous expression of SeMet-labelled
proteins, the thisA gene was subcloned into pET11c. To this end,
thisA was ampli¢ed by PCR using the plasmid pUN121/III as a tem-
plate [5]. The oligonucleotide 5P-AAGGTGATCATATGCTCGTT-
GTCC-3P with a NdeI site (in bold) was used as the 5P-primer and
the oligonucleotide 5P-GAGACACGGGATCCTTCTTTTAGC-3P in-
troducing a BamHI site (in bold) was used as the 3P-primer. The
ampli¢ed DNA fragment was cloned into pET11c using the two
new restriction sites to yield the plasmid pET11c-thisA.
E. coli B834(DE3)/pLys cells were transformed with pET11c-thisF
or pET11c-thisA and streaked out on LB plates supplemented with
150 Wg/ml ampicillin and 35 Wg/ml chloramphenicol. For con¢rming
methionine auxotrophy, two colonies from each LB plate harbouring
cells with pET11c-thisF or pET11c-thisA were resuspended in Vogel-
Bonner minimal medium [14], supplemented per l with 1 mg thiamine,
2 g glucose, 150 mg ampicillin, 35 mg chloramphenicol, a heavy metal
mix containing 10 mg MoNa2O4, 2 mg CoCl2, 2 mg CuSO4W5H2O,
10 mg MnCl2W4H2O, 10 mg ZnCl2, 5 mg FeSO4W7H2O, 50 mg
CaCl2W2H2O, 10 mg H3BO3, an amino acid mix containing 50 mg
of each tryptophan, tyrosine, valine, isoleucine, leucine, serine, cys-
teine, aspartate, glutamate, lysine, arginine, histidine, alanine, threo-
nine and optionally 50 mg methionine or D/L-SeMet, and streaked out
on minimal medium plates with or without methionine. Clones with a
con¢rmed methionine auxotrophy were used to inoculate 50 ml of
minimal medium containing methionine. These pre-cultures were
shaken at 200 rpm and 37‡C for 20 h. Two 10 ml portions were
used to inoculate two 1 l cultures each containing the same medium
and shaking was continued at 100 rpm and 37‡C. After the OD600 had
reached a value of 0.6, the cultures were centrifuged (Sorvall RC-3B,
4500 rpm, 30 min, 4‡C) and the cells were resuspended in the same
volume of pre-warmed minimal medium lacking methionine. The cul-
tures were then incubated for another 8 h under the same conditions
for consumption of residual methionine. During this incubation, the
OD600 increased only slightly to a value of 0.62. 50 mg D/L-SeMet was
added and the culture was shaken for another 2 h, during which the
OD600 increased to a value of 0.8. Expression of SeMet containing
tHisA ([SeMet]tHisA) or tHisF ([SeMet]tHisF) was induced by adding
IPTG to a ¢nal concentration of 1 mM, followed by incubation for
another 12 h. Cells were centrifuged (Sorvall RC-3B, 4500 rpm,
30 min, 4‡C), washed with 100 mM potassium phosphate bu¡er at
pH 7.8, containing 2 mM EDTA and 5 mM DTT, and centrifuged
again (Sorvall RC-5Cplus, SS34 rotor, 8000 rpm, 20 min, 4‡C). About
3.8 g of [SeMet]tHisA and 6.4 g of [SeMet]tHisF wet cells were ob-
tained from 2 l cultures each.
All bu¡ers contained 5 mM DTT during puri¢cation of both
[SeMet]tHisA and [SeMet]tHisF in order to prevent oxidation of
SeMet [15]. The puri¢cation of [SeMet]tHisA followed the established
procedure for wild-type tHisA as described above. The only change in
the puri¢cation protocol was the use of a smaller DEAE-Sephacel
column (3.5U25.4 cm), with a total gradient volume of 1.5 l. Peak
fractions of pure [SeMet]tHisA eluting from the Red Sepharose col-
umn were pooled and dialysed against 10 mM potassium phosphate at
pH 7.5, containing 1 mM EDTA and 5 mM DTT. The puri¢cation
FEBS 22211 25-6-99
R. Thoma et al./FEBS Letters 454 (1999) 1^62
yielded 13.3 mg of [SeMet]tHisA per g of wet cells. [SeMet]tHisA was
concentrated to 17 mg/ml and shock-frozen in liquid nitrogen.
About 80% of [SeMet]tHisF was found in the soluble fraction of
the cell homogenates, in contrast to only about 50% in the case of
native tHisF. [SeMet]tHisF was puri¢ed essentially as described for
native tHisF, with the following exceptions. A smaller DEAE-Sephar-
ose fast-£ow column (2.5U29 cm) was used, with a total gradient
volume of 0.9 l. Furthermore, the last puri¢cation step with hydrox-
ylapatite was omitted. Peak fractions of pure [SeMet]tHisF from the
DEAE-Sepharose column were pooled and dialysed against 10 mM
potassium phosphate at pH 7.5, containing 2 mM EDTA and 5 mM
DTT. The puri¢cation yielded 11.7 mg of [SeMet]tHisF per g wet
cells. [SeMet]tHisF was concentrated to 24.6 mg/ml (PM10 mem-
branes, Amicon) and shock-frozen in liquid nitrogen.
2.4. Reversed phase HPLC
Reversed phase HPLC was performed on a Hewlett Packard HPLC
workstation (TI-SERIES 1050). The protein samples were acidi¢ed
with 0.1% (v/v) TFA and aggregated material was removed by cen-
trifugation. The supernatants (total volume of 150 Wl containing 35 Wg
tHisA, 42 Wg [SeMet]tHisA, 100 Wg tHisF or 160 Wg [SeMet]tHisF
each) were loaded on a Vydac C18 218TP54 column, eluted with a
gradient of 1.6^64% acetonitrile in 0.08% (v/v) TFA at £ow rates of
1 ml/min and monitored at 278 nm.
2.5. Electrospray mass spectrometry
Electrospray mass spectrometry was performed with tHisF and
[SeMet]tHisF. Mass determinations were carried out on a TSQ7000
triple quadrupole mass spectrometer (Finnigan, San Jose¤, CA, USA).
All measurements were carried out in the positive ion mode, scanning
between 200 and 2000 Da. The resolution of the instrument was set to
1 Da. The protein was introduced into a micro ion source [16] by
injection onto a 100 Wm in diameter capillary column packed with
POROS R2 (20 Wm particle size, 3^5 cm in length). Desorption was
performed with a 10 min gradient consisting of 0^80% acetonitrile in
0.02% acetic acid at £ow rates of 100^200 nl/min. The spray voltage
was set to 1100 V.
2.6. Crystallisation and preliminary X-ray characterisation
Crystallisation trials were set up as vapour di¡usion experiments
using the hanging drop method on siliconised cover slips over 1 ml
reservoir limbro multi-well tissue culture plates (ICN Biomedicals,
Eschwege, Germany). Crystallisation drops consisted of 2.0 Wl con-
centrated protein as described above and 2.0 Wl reservoir solution and
trials were maintained at 20‡C. Crystallisation conditions were
screened by the protocol of Jancarik and Kim [17] using the multi-
factorial crystal screens (Hampton Research, Riverside, USA). Initial
successful crystallisation conditions were further optimised by varying
the concentration of protein, precipitant and bu¡er system as well as
the pH. Some crystals were further improved by the macroseeding
method [18]. Seeds were obtained by either crushing larger twinned
crystals or by using smaller ones. The concentration of the precipitant
in macroseeding experiments was lowered by 50%.
The di¡raction properties of crystals were investigated by collecting
test X-ray images. Crystals were mounted into thin-walled capillaries
with diameters between 0.4 and 1.0 mm (Mueller, Berlin, Germany).
Alternatively, crystals were mounted into nylon cryo loops (Hampton
Research, Riverside, USA) and shock-frozen in a nitrogen stream at
100 K (Oxford Cryosystem, UK). Test images were recorded on one
of the protein crystallography synchrotron beam lines at the EMBL
Hamburg Outstation.
3. Results
3.1. Heterologous expression and puri¢cation of tHisA, tHisF
and their SeMet derivatives
Di¡erent expression plasmids, pDS56/RBS II and pET11c,
were used for the production of tHisA and tHisF in E. coli. In
the pDS system, proteins are expressed under the control of a
lac promoter/repressor system, in which the expression can be
induced by IPTG [10]. In the pET system, proteins are ex-
pressed from a phage T7 promoter, the phage T7 polymerase
being encoded on the chromosome of the host cells [13].
About 90% of tHisA and 50% of tHisF were found in the
soluble fractions of the cell homogenate. Since slow refolding
and a high tendency to aggregate often hamper the refolding
of thermostable proteins ([19], Sterner, unpublished observa-
tions), both tHisA and tHisF were puri¢ed from the soluble
extracts only. The main puri¢cation step for both enzymes
was the heating of the extracts to 75‡C for 15 min, which
removed more than 80% of the E. coli host proteins. Subse-
quent puri¢cation steps included anion exchange chromatog-
raphy, followed by a⁄nity chromatography on Red Sephar-
ose for tHisA and hydroxylapatite chromatography for tHisF.
The ¢nal yields were 1.15 mg of tHisA and 2.3 mg of tHisF
per g wet cells.
The molar extinction coe⁄cients of tHisA and tHisF at
280 nm were determined from the amino acid sequence [20].
For tHisA, a value of O280 = 12 950 M31 cm31 was calculated.
This value is similar to O280 = 11 060 M31 cm31 as determined
by second derivative spectroscopy according to Levine and
Federici [21]. With a molecular mass of 27 031 Da [5], this
corresponds to A0:1%280 = 0.41 cm
2 mg31. For tHisF, a value of
O280 = 11 500 M31 cm31 was calculated. With a molecular
mass of 27 719 Da [5], this corresponds to A0:1%280 = 0.42 cm
2
mg31.
The SeMet derivatives [SeMet]tHisA and [SeMet]tHisF
were expressed using the pET system and E. coli B834(DE3)
Fig. 1. Puri¢cation of [SeMet]tHisA (A) and [SeMet]tHisF (B) from
transformed E. coli cells monitored by electrophoresis on 12.5%
polyacrylamide gels in the presence of SDS. Lanes M, standard pro-
teins with molecular weights given in kDa; lanes 1, insoluble frac-
tions of the cell extracts; lanes 2: soluble fractions of the cell ex-
tracts; lanes 3: supernatants after heat steps (15 min, 75‡C); lanes
4: eluates from DEAE-Sephacel FF (A) or DEAE-Sepharose FF
(B) column; lane 5: eluate from Red Sepharose FF column.
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cells containing the plasmid pLys, which encodes the phage
T7 lysozyme. T7 lysozyme is an inhibitor of phage T7 polym-
erase, providing a tight repression of transcription in the ab-
sence of IPTG. The yields for [SeMet]tHisA and [SeMet]tHisF
were 13 mg and 12 mg per g wet cells, which is about 10 and
¢ve times higher compared to the native proteins. These large
di¡erences are probably due to the small scale expression of
[SeMet]tHisA and [SeMet]tHisF being carried out in glass
£asks, instead of the large scale expression of the native pro-
teins being carried out in a fermenter. In addition, for
[SeMet]tHisA, the use of a pET instead of the pDS plasmid
could have resulted in a higher expression level and for
[SeMet]tHisF, the omission of the hydroxylapaptite column
might have reduced the loss of protein during puri¢cation.
3.2. Purity and SeMet content of proteins
Fig. 1 shows that the purity of [SeMet]tHisA and [SeMet]-
tHisF followed by SDS-PAGE is at least 90%. Similar results
were obtained for native tHisA and tHisF (data not shown).
Reversed phase HPLC, performed with [SeMet]tHisF and us-
ing an acetonitrile gradient for elution (Fig. 2), gives a purity
better than 98%. Similar purities were obtained also for
[SeMet]tHisA, tHisA and tHisF (data not shown).
Electrospray mass spectrometry was performed with native
tHisF and [SeMet]tHisF to analyse the content of SeMet (Fig.
3). The observed molecular masses were 27 723.5 þ 3.1 Da for
tHisF and 27 959 þ 3.6 Da for [SeMet]tHisF. The di¡erence
between the two masses (236 Da) corresponds accurately to
the mass di¡erence expected for replacing the ¢ve methionines
of tHisF completely by SeMets.
3.3. Crystals of tHisA
Crystals of tHisA were obtained under four di¡erent crys-
Fig. 3. [SeMet]tHisF is completely labelled with SeMet. Electrospray
mass spectra of tHisF (A) and [SeMet]tHisF (B) were obtained on a
TSQ7000 triple quadrupole mass spectrometer. The labelled peaks
indicate the charge states of measured m/z values of the two pro-
teins. [M+H] indicates the mass of the two proteins (27 723.5 þ 3.1
Da for tHisF and 27 959 þ 3.6 Da for [SeMet]tHisF) as obtained
after deconvolution of the measured m/z values. The mass di¡erence
of 236 Da shows that all ¢ve methionine residues in tHisF are com-
pletely replaced by SeMet in [SeMet]tHisF.
Fig. 2. Reversed phase HPLC testi¢es to a high purity of [SeMet]-
tHisF. Elution of 160 Wg protein was performed at 1 ml/min with
an acetonitrile gradient (1.6^64%, dotted line) in 0.08% tri£uroacetic
acid and monitored on-line at 278 nm. [SeMet]tHisF eluted as a
symmetrical peak at 58 min and integration of the peak areas
yielded a purity of at least 98%.
Table 1
Crystallisaton conditions
Name Precipitant Bu¡er Additives
tHisA-1 25% (v/v) PEG MME 500 0.1 M MES/NaOH, pH 6.5 10 mM ZnSO4, 10% (v/v) glycerol
tHisA-2 18% (w/v) PEG 8000 0.1 M Na-cacodylate/HCl, pH 6.6 200 mM Ca(Ac)2
tHisA-3 29^35% (w/v) PEG 4000 0.1 M citrate, pH 5.6 200 mM NH4Ac, 3% (v/v) MPD
tHisA-4 28% (w/v) PEG 4000 0.1 M citrate, pH 5.6 200 mM NH4(H2PO4), 3% (v/v) MPD
tHisF 0.9^1.2 M NH4(H2PO4) 0.1 M citrate, pH 5.6
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tallisation conditions within the pH range from 5.6 to 6.6 and
were always comprising polyethyleneglycols (PEG) of a di¡er-
ent molecular weight as precipitants (Table 1). The main dif-
ferences are the nature of the ionic additives. Since the sub-
strate of tHisA, 5P-ProFAR, contains two phosphate groups,
it is expected that in tHisA-1 and tHisA-4, sulfate or phos-
phate anions are bound to the active site, respectively. All the
four crystal forms display distinct habits and crystallographic
parameters (Table 2). Similarities in the unit cell dimensions
indicate related packing arrangements with permutations of
the crystallographic axes. Crystal forms tHisA-1 and tHisA-
3 have similar unit cell dimensions of about 47 AîU80 AîU62
Aî (c/2 in crystal tHisA-1). The crystal packing parameter VM
[22] suggests one and two molecules per asymmetric unit for
tHisA-1 and tHisA-3, respectively. Crystal forms tHisA-2 and
tHisA-4 both have P212121 symmetry and related cell dimen-
sions of 78 Aî (a in tHisA-2, b in tHisA-4)U70 Aî (c/2 in
tHisA-2, a in tHisA-4)U105 Aî (b in tHisA- 2, c/2 in tHisA-
4). Since crystal forms 3 and 4 display superior di¡raction
qualities, they will be further used for structural analysis.
These two crystal forms have been obtained and tested with
[SeMet]tHisA too.
3.4. Crystals of tHisF
Crystals of tHisF and [SeMet]tHisF were obtained with
ammonium phosphate as precipitant (Table 1). Initial crystals
grew within days as small multicrystalline clusters. Single crys-
tals, obtained by macroseeding, grew to a maximum size of
400 WmU250 WmU250 Wm. These tHisF crystals di¡ract to
about 1.0 Aî resolution (Table 2). Interestingly, their unit cell
parameters are similar to those of tHisA-3 crystals, suggesting
similarities in the shape of the molecules and crystal packing
arrangement.
4. Discussion
4.1. Use of thermostable proteins for X-ray crystallography
Tryptophan biosynthesis is the ¢rst amino acid biosynthetic
pathway for which the crystal structures of all enzymes have
been determined ([3] and citations within, [23]) or where struc-
ture determination is in progress (Mayans, O., Ivens, A.,
Kirschner, K. and Wilmanns, M., unpublished results). In
the tryptophan biosynthesis, progress in structure determina-
tion was hampered for many years by di⁄culties in crystallis-
ing enzymes from mesophilic species. The switch to trypto-
phan enzymes from hyperthermophiles such as Sulfolobus
sulfataricus and T. maritima facilitated the crystallisation
and structure determination of unliganded structures as well
as of various ligand complexes. Based on this experience with
tryptophan enzymes, we chose thermostable variants in order
to grow crystals for structure determination of two enzymes
of the histidine biosynthesis. The e⁄ciency of puri¢cation and
crystallisation of tHisA and tHisF from the hyperthermophile
T. maritima con¢rms our expectations, underscoring the spe-
ci¢c advantages of proteins from hyperthermophiles for X-ray
crystallography. Hyperthermophilic proteins display a high
solubility and overall rigidity at temperatures where crystalli-
sation is performed [24]. We speculate that these properties
contribute to the increased tendency of thermostable proteins
to yield excellent crystals with a higher probability than their
thermolabile orthologues.
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